Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2012; 18(32): 4419-4426
Published online Aug 28, 2012. doi: 10.3748/wjg.v18.i32.4419
Published online Aug 28, 2012. doi: 10.3748/wjg.v18.i32.4419
Figure 1 Circulating tumour cells are separated from the leucocytes using magnetic beads coupled with epithelial cell adhesion molecule antibody and a magnetic device.
These complexes are then tagged with cytokeratin-19 (CK19) biotinylated antibody and streptavidin-conjugated quantum dots (QDs) which lead to the detection of a fluorescent signal. EpCAM: Epithelial cell adhesion molecule; DLD-1: Human colon adenocarcinoma cell line.
- Citation: Gazouli M, Lyberopoulou A, Pericleous P, Rizos S, Aravantinos G, Nikiteas N, Anagnou NP, Efstathopoulos EP. Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection. World J Gastroenterol 2012; 18(32): 4419-4426
- URL: https://www.wjgnet.com/1007-9327/full/v18/i32/4419.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i32.4419